Orca Wealth Management LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 34,527 shares of the pharmacy operator's stock, valued at approximately $322,000.
A number of other large investors have also recently added to or reduced their stakes in WBA. State Street Corp increased its stake in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. raised its position in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock valued at $98,284,000 after acquiring an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator's stock valued at $68,046,000 after acquiring an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its position in Walgreens Boots Alliance by 15.5% during the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator's stock valued at $62,325,000 after acquiring an additional 934,754 shares in the last quarter. Finally, FMR LLC raised its position in shares of Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator's stock valued at $29,200,000 after purchasing an additional 80,525 shares during the period. 58.59% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Stock Performance
NASDAQ:WBA traded up $0.36 during mid-day trading on Wednesday, hitting $11.25. The company's stock had a trading volume of 16,850,817 shares, compared to its average volume of 28,941,332. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market cap of $9.72 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.46 and a beta of 0.64. The business's fifty day moving average is $9.96 and its two-hundred day moving average is $9.86.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 EPS. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on WBA. TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a report on Tuesday, October 22nd. Truist Financial upped their price target on Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a "hold" rating in a research report on Thursday, January 16th. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a research note on Friday, October 11th. UBS Group increased their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a "neutral" rating in a research note on Thursday, October 17th. Finally, Evercore ISI increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $13.27.
View Our Latest Stock Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
